CTOs on the Move

Well Point

www.wellpont.com

 
Well Point is a Half Moon Bay, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.wellpont.com
  • 728 Arroyo Leon Dr
    Half Moon Bay, CA USA 94019
  • Phone: 650.560.9803

Executives

Name Title Contact Details

Similar Companies

Vial

Vial is a leading clinical trial site network that runs highly efficient clinical trials. Vial operates a network of clinical trial research sites within Dermatology clinics across the country. Vials clinical trial recruiting engine, software and oper...

ASG Medical Systems

ASG Medical Systems is a West Palm Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bethesda Gardens At Fort Worth

Bethesda Gardens At Fort Worth is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CLMBR

A machine built to move with you. CLMBR offers a unique combination of high intensity cardio, resistance strength training, and connected technology.

PanOptica

At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.